🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: 1 (Lipitor®, Ezetrol®)

Found 10 matching trials

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

PHASE1

A randomized open-label, multiple dose, three-treatment, three-period, six-...

Status

Completed

Location

ChongKunDang

Start Date

2014-11

Trial ID

NCT02288338

Treatments Being Tested

1 (Lipitor®)1 (Ezetrol®)1 (Lipitor®, Ezetrol®)2 (Ezetrol®)2(Lipitor®, Ezetrol®)2 (Lipitor®)3(Lipitor®, Ezetrol®)3 (Lipitor®)3 (Ezetrol®)4 (Lipitor®)4(Lipitor®, Ezetrol®)4 (Ezetrol®)5 (Ezetrol®)5 (Lipitor®)5 (Lipitor®, Ezetrol®)6(Lipitor®, Ezetrol®)6 (Ezetrol®)6 (Lipitor®)

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)

PHASE3

The purpose of this study is to determine whether ezetimibe/atorvastatin 10...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01370590

Treatments Being Tested

Atorvastatin Ezetimibe Ezetimibe/atorvastatin Placebo to atorvastatin Placebo to ezetimibe Placebo to ezetimibe/atorvastatin

Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin

PHASE1

Monotherapies for lowering LDL-C often do not achieve target lipid levels b...

Status

Completed

Location

Research Site

Start Date

2025-12-09

Trial ID

NCT07268625

Treatments Being Tested

Bempedoic acid Ezetimibe Atorvastatin

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

PHASE3

This is a multicenter, randomized, double-blind, placebo-controlled, balanc...

Status

Completed

Location

Multiple Locations

Start Date

2000-03-06

Trial ID

NCT03867110

Treatments Being Tested

Placebo Ezetimibe 10 mg Atorvastatin 10 mg Atorvastatin 20 mg Atorvastatin 40 mg Atorvastatin 80 mg

Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)

PHASE3

The primary purpose of this study is to evaluate the long-term safety and t...

Status

Completed

Location

Multiple Locations

Start Date

2000-10-25

Trial ID

NCT03885921

Treatments Being Tested

Ezetimibe Atorvastatin Simvastatin

A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin

PHASE1

Monotherapies for lowering LDL-C often do not achieve target lipid levels b...

Status

Completed

Location

Research Site

Start Date

2025-10-28

Trial ID

NCT07235189

Treatments Being Tested

Bempedoic acid Ezetimibe Atorvastatin

Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

PHASE3

The overall objective is to evaluate the efficacy and safety of ezetimibe (...

Status

Completed

Location

Multiple Locations

Start Date

2000-04-24

Trial ID

NCT03867318

Treatments Being Tested

Atorvastatin Ezetimibe Placebo for Ezetimibe Placebo for Atorvastatin

A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

PHASE3

The purpose of this study is to determine whether ezetimibe/atorvastatin 10...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01370603

Treatments Being Tested

Atorvastatin Ezetimibe Ezetimibe/atorvastatin Placebo to atorvastatin Placebo to ezetimibe Placebo to ezetimibe/atorvastatin

A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)

PHASE3

The purpose of this study was to evaluate the long-term safety and tolerabi...

Status

Completed

Location

Multiple Locations

Start Date

2000-10-06

Trial ID

NCT03882996

Treatments Being Tested

Ezetimibe Atorvastatin

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

PHASE3

The primary objective is to determine the efficacy of AMR101 (ethyl icosape...

Status

Completed

Location

Amarin Investigational Site

Start Date

2009-12

Trial ID

NCT01047683

Treatments Being Tested

AMR101 (ethyl icosapentate) - 4 g/day AMR101 (ethyl icosapentate) - 2 g/day Placebo

Previous Next